| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001902 Cyclization in presence of Lawesson's reagent |
| 02/21/2006 | US7001898 Treating conditions involving increased vascular resistance and cardiac insufficiency. |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2187315C 4,6-di-t-butyl-2,3-dihydrobenzothiophene derivatives |
| 02/21/2006 | CA2116165C Substituted benzenesulfonylureas and -thioureas - processes for their preparation and their use as pharmaceuticals |
| 02/21/2006 | CA2110443C Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 02/16/2006 | WO2006016682A1 Ameliorant for blood vessel elasticity and use thereof |
| 02/16/2006 | WO2006016637A1 Novel cyclic aminobenzoic acid derivative |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006015930A1 Phenol derivatives |
| 02/16/2006 | WO2006015522A1 A capsule for regulation of blood pressure and hyperlipemia and prevention and treatment of cardiovascular and cerebrovascular diseases |
| 02/16/2006 | WO2005115378B1 Compositions comprising flavonoids and tocotrienols and methods thereof |
| 02/16/2006 | WO2005115377B1 Functional foods comprising flavonoids and tocotrienols and methods thereof |
| 02/16/2006 | WO2003025129A3 Neurotransmission-associated proteins |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060036074 Bromodomain protein |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035977 Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same f |
| 02/16/2006 | US20060035971 Blood fluidity improving agent |
| 02/16/2006 | US20060035959 e.g. (dibenzofuran-4-yl)-(3,5-dichlorophenylamino)acetic acid; glycine B antagonist on the NMDA receptor complex for regulating the calcium balance; analgesic,antiinflammatory, antidepressant, anxiolytic agent, neurodegenerative diseases; chronic and neuropathic pain |
| 02/16/2006 | US20060035948 e.g. 6-nitro-4-[N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amino]-3-hydroxy-2-methyl-2-dimethoxymethyl-3,4-dihydro-2H-1-benzopyran; protecting neuronal cells from oxidative stress induced cell death by iron or by hydrogen peroxide; antihypoxic agent, neuroprotectant |
| 02/16/2006 | US20060035941 Calcium salts of indole derived statins |
| 02/16/2006 | US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035878 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035868 2' Hydroxy-3'-bromo-3,4,4',5-tetramethoxy-(Z)-stilbene; antimitotic agent; inhibits the assembly of tubulin into microtubules; anticarcinogenic: solid tumor cancers, neovascularization; tubulin-binding stilbenoid analogs structurally related to combretastatin A-1 and A-4 (extract from willow tree) |
| 02/16/2006 | US20060035865 Lipid-rich plaque regressing agents |
| 02/16/2006 | US20060035851 Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair |
| 02/16/2006 | US20060035847 e.g. 1,2-Dihydro-4-[(4-isopropoxyphenyl)methyl]-5-methyl-3H-pyrazol-3-one; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; antidiabetic and hyperglycemic agents; obesity; synergistic mixture with other active compounds |
| 02/16/2006 | US20060035840 Beta-D-Glucopyranosyloxy)-3-(3-fluoro-4-methylbenzyl)-4,6-dimethylpyridine; sodium glucose co-transporter 2 (SGLT2) inhibitors; excellent hypoglycemic effect by excreting excess glucose into the urine through preventing the reabsorption of glucose at the kidney; antidiabetic agents; hyperglycemia |
| 02/16/2006 | US20060035836 Treatment of acute coronary syndrome with an exendin |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035303 JNK3 modulators and methods of use |
| 02/16/2006 | US20060035299 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 02/16/2006 | US20060035263 DRG11-responsive (DRAGON) gene family |
| 02/16/2006 | US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs |
| 02/16/2006 | US20060034772 Composition comprising low density microspheres |
| 02/16/2006 | DE102004035322A1 Selektive Hemmstoffe humaner Corticoidsynthasen Selective inhibitors of human Corticoidsynthasen |
| 02/16/2006 | DE102004034640A1 Verfahren zur systemischen Biokorrektur eines Organismus Method for systemic Biokorrektur an organism |
| 02/16/2006 | DE102004034573A1 Composition for treating pulmonary and coronary vascular diseases and metabolic diseases comprises L-arginine/ornithine, L-lysine, L-carnitine and L-cysteine in an isotonic sodium chloride solution |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2575907A1 Novel uses of 2-phenyl-substituted imidazotriazinone derivatives |
| 02/16/2006 | CA2575849A1 Combination therapies employing vitamin b6 related compounds and ace inhibitors and uses thereof for the treatment of diabetic disorders |
| 02/16/2006 | CA2575123A1 Peptide sequence for modulation of delta protein kinase c |
| 02/16/2006 | CA2575039A1 Novel cyclic amino benzoic acid derivative |
| 02/16/2006 | CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/15/2006 | EP1626048A1 Crystal of benzimidazole derivative and process for producing the same |
| 02/15/2006 | EP1625860A1 Kit for applying drug coating to a medical device with a latex emulsion |
| 02/15/2006 | EP1625858A1 Compounds for treating ischemic tissue |
| 02/15/2006 | EP1625848A1 Composition and method for enhanced delivery of 5,5-diphenyl barbituric acid |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625213A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
| 02/15/2006 | EP1625166A1 Antibodies to masp-2 |
| 02/15/2006 | EP1624877A2 Use of steroid derivatives for the treatment of angiotensin ii related diseases e.g. cardiovascular and proliferative disorders |
| 02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 02/15/2006 | EP1341533B1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 02/15/2006 | EP1267865B1 Amiodarone-containing parenteral solution |
| 02/15/2006 | EP1224207B1 5-hydroxysapogenin derivatives with anti-dementia activity |
| 02/15/2006 | EP1154767B1 Substituted stilbene compounds with vascular damaging activity |
| 02/15/2006 | CN1735603A Benzomorpholine derivatives |
| 02/15/2006 | CN1735416A Therapeutic combination |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 02/15/2006 | CN1735402A Polymer composition including large ring alkatriene compound |
| 02/15/2006 | CN1733792A Cyclovirobuxine extraction and purification method |
| 02/15/2006 | CN1733733A Novel alkali B of cohosh root and its uses in preparing anti-myocardial ischemia drug |
| 02/15/2006 | CN1733727A Crystalline carvedilol, processes for the manufacture thereof, pharmaceutical compositions and uses thereof |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1733723A Indole and dihydroindole derivatives |
| 02/15/2006 | CN1733714A Fumaric acid ibutilide synthesis method |
| 02/15/2006 | CN1733704A Synthesis and biological and pharmacological action of betaine salicylate |
| 02/15/2006 | CN1733307A Antihypertensive combination of valsartan and calcium channel blocker |
| 02/15/2006 | CN1733257A Chinese traditional medicine capsule for curing essential hypotension, process for preparing the same and quality controlling method thereof |
| 02/15/2006 | CN1733253A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 02/15/2006 | CN1733243A Garlic medicinal liquor for curing cardiopathy |
| 02/15/2006 | CN1733242A Medicine for curing qi deficiency induced thoracic obstruction (coronary heart disease) and technique for preparing the same |
| 02/15/2006 | CN1733209A Injection for restoring pulse beat and process for preparing the same |
| 02/15/2006 | CN1733208A Chinese traditional medicine preparation for treating coronary heart disease and process for preparing the same |
| 02/15/2006 | CN1733207A Medicine composition for treating essential hypotension |
| 02/15/2006 | CN1733198A Oral liquid for curing myocardial ischemia and process for preparing the same |
| 02/15/2006 | CN1733193A Chinese traditional medicine for treating cardiopathy |
| 02/15/2006 | CN1733160A Obstruction relaxing plaster |
| 02/15/2006 | CN1733153A Chinese traditional medicine capsule for treating apoplexy, its preparation process and quality control method |
| 02/15/2006 | CN1733151A Health caring medical liquor containing wine processed grape |
| 02/15/2006 | CN1733143A Aimal liver concentration tablet and technique for preparing the same |
| 02/15/2006 | CN1733135A Oral liquid for curing women's climacteric melancholia and process for preparing the same |
| 02/15/2006 | CN1733118A Chinese medicine for treating piles |
| 02/15/2006 | CN1733117A Process for preparing plaster to treat hypertension |
| 02/15/2006 | CN1733116A Medicinal preparation for treating hypertension and its preparing process |
| 02/15/2006 | CN1733113A Hemorrhoid-eliminating suppository with garden burnet and process for preparing the same |
| 02/15/2006 | CN1733109A Soft capsule for treating coronary disease and process for preparing the same |
| 02/15/2006 | CN1733107A Medicine for treating coronary disease and apoplexy sequelae and process for preparing the same |
| 02/15/2006 | CN1733092A Effective ingredients of Chinese medicine moutan bark and preparation method thereof |
| 02/15/2006 | CN1733091A Finely prepared controlled release preparation for coronary disease and its preparation process |